My Cart

GLP1R

GLP1R Overview

English NameGlucagon-like peptide-1Approved Drugs0
Drugs in Clinical Trials13Target SynonymGLP-1
Highest Development StagePhase 3 Clinical
English NameGlucagon-like peptide-1
Target SynonymGLP-1
Approved Drugs0
Drugs in Clinical Trials13
Highest Development StagePhase 3 Clinical

GLP1R Background

G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1

GLP1R Synonyms

GLP-1-R, GLP-1R, glucagon like peptide 1 receptor

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BioGlutideNA-931Phase 3 ClinicalBiomed Industries IncBody Weight; Body Weight Changes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight; Weight Loss
Details
BionetideNA-921Phase 3 ClinicalBiomed Industries IncFragile X Syndrome; Rett Syndrome
Details
ZT-006ZT-006; ZT006Phase 2 ClinicalBeijing QL Biopharmaceutical Co LtdAlzheimer Disease; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight
Details
HM-15275HM15275; HM-15275Phase 2 ClinicalHanmi Pharmaceutical Co LtdObesity
Details
SYH-2082SYH-2082; SYH2082Phase 1 ClinicalBeijing Kangchuanglian Biopharmaceutical Technology Research Co LtdObesity; Overweight
Details
SNA-003SNA003; SNA-003Phase 1 ClinicalSN BioScienceDiabetes Mellitus; Obesity
Details
CA-111CA-111; CA111Phase 1 ClinicalChongqing Chenan Biopharmaceutical Co LtdBody Weight
Details
ACT-300ACT300; ACT-300Phase 1 ClinicalXiamen Amoytop Biotech Co LtdDigestive System Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
KAI-4729HRS-4729; KAI-4729Phase 1 ClinicalJiangsu Hengrui Medicine Co LtdMetabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Overweight
Details
ZT-003ZT003; ZT-003Phase 1 ClinicalBeijing QL Biopharmaceutical Co LtdDiabetes Mellitus; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
ANY-002ANY-002; ANY002Phase 1 ClinicalAnya Biopharm Inc
Details
KN-069KN069; KN-069Phase 1 ClinicalSuzhou Alphamab Co LtdMetabolic Diseases; Obesity; Overweight
Details
semaglutide (Lexaria Bioscience)ClinicalLexaria Bioscience CorpDiabetes Mellitus
Details
  • Overview
  • Product List
  • Clinical Drug Information